Research and Markets (http://www.researchandmarkets.com/research/cbjzwk/global_diabetic) has announced the addition of the "Global Diabetic Neuropathy Epidemiology and Patient Flow Analysis - 2015" report to their offering.
This report provides insights into Diabetic Neuropathy epidemiology, Diabetic Neuropathy diagnosed patients, and Diabetic Neuropathy treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Diabetic Neuropathy derived from epidemiological analysis, percentage of patients diagnosed with Diabetic Neuropathy, and percentage of patients treated with Diabetic Neuropathy therapy.
The study helps executives estimate Diabetic Neuropathy market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Diabetic Neuropathy prevalence, Diabetic Neuropathy diagnosis rate, and Diabetic Neuropathy treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Topics Covered:
1. Diabetic Neuropathy: Disease Definition
2. Global Diabetic Neuropathy Patient Flow
3. Diabetic Neuropathy Patient Flow in the US
4. Diabetic Neuropathy Patient Flow in Europe
5. Diabetic Neuropathy Patient Flow in Germany
6. Diabetic Neuropathy Patient Flow in France
7. Diabetic Neuropathy Patient Flow in Spain
8. Diabetic Neuropathy Patient Flow in Italy
9. Diabetic Neuropathy Patient Flow in UK
10. Diabetic Neuropathy Patient Flow in Japan
11. Appendix
For more information visit http://www.researchandmarkets.com/research/cbjzwk/global_diabetic
